PTIX
Protagenic Therapeutics, Inc.\new · Healthcare · Market cap $1.4M
Insiders bought $31K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Aug 24, 2026
Insider Buying
$31K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 24, 2026
ARMEN GARO H
Protagenic Therapeutics, Inc.\new (PTIX) has 7 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
Inside the rolling window, 1 insider at Protagenic Therapeutics, Inc.\new reported 7 open-market purchases totaling $31K and no open-market sales. The most active filer is EXEC. CHAIR & PRINCIPAL OFF ARMEN GARO H with 7 filings. The most recent open-market filing is a purchase of 20,000 shares by EXEC. CHAIR & PRINCIPAL OFF ARMEN GARO H, dated Aug 21, 2026, worth $13K.
- Industry:Biotechnology
- CEO:Garo H. Armen
- Employees:2
- HQ:New York, NY, US
- IPO:2021-04-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 20,000 | $13K | Aug 24 | -31.2% | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 16,634 | $10K | Aug 21 | -6.4% | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 2,700 | $945 | Aug 20 | +25.0% | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 2,220 | $710 | Aug 12 | +108.3% | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 685 | $151 | Aug 10 | +114.3% | SEC ↗ | |
| EXEC. CHAIR & PRINCIPAL OFF | Purchase | 5,000 | $1K | Aug 7 | +141.9% | SEC ↗ | |
ARMEN GARO HFirst filing | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 26,291 | $5K | Aug 3 | +309.8% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does PTIX have?
Protagenic Therapeutics, Inc.\new (PTIX) has 7 SEC Form 4 filings (7 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for PTIX?
The most recent Form 4 filing for PTIX on Tracefour is dated Aug 24, 2026.
Who is the most active insider at PTIX?
The most active SEC Form 4 filer at PTIX in the rolling window is EXEC. CHAIR & PRINCIPAL OFF ARMEN GARO H, with 7 filings.
What is the net insider flow at PTIX over the last 6 months?
Over the trailing 180 days, insiders at PTIX have net bought $31K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PTIX in the current window?
Inside the rolling window, insiders at PTIX bought $31K and sold $0 based on SEC Form 4 filings.
Can I get alerts for PTIX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Protagenic Therapeutics, Inc.\new (PTIX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Protagenic Therapeutics, Inc.\new is in the Healthcare sector.